JP2006510654A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006510654A5 JP2006510654A5 JP2004558236A JP2004558236A JP2006510654A5 JP 2006510654 A5 JP2006510654 A5 JP 2006510654A5 JP 2004558236 A JP2004558236 A JP 2004558236A JP 2004558236 A JP2004558236 A JP 2004558236A JP 2006510654 A5 JP2006510654 A5 JP 2006510654A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- formulation according
- kinase inhibitor
- patient
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43124102P | 2002-12-06 | 2002-12-06 | |
| PCT/US2003/040140 WO2004053107A2 (en) | 2002-12-06 | 2003-12-05 | Methods for treating diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006510654A JP2006510654A (ja) | 2006-03-30 |
| JP2006510654A5 true JP2006510654A5 (https=) | 2007-02-01 |
Family
ID=32507688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004558236A Pending JP2006510654A (ja) | 2002-12-06 | 2003-12-05 | 糖尿病を処置する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040171659A1 (https=) |
| EP (1) | EP1583535A4 (https=) |
| JP (1) | JP2006510654A (https=) |
| AU (1) | AU2003299652A1 (https=) |
| CA (1) | CA2511763A1 (https=) |
| WO (1) | WO2004053107A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7765004B2 (en) * | 2005-04-28 | 2010-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for managing fusion and noise in cardiac pacing response classification |
| WO2007075896A2 (en) * | 2005-12-22 | 2007-07-05 | Kemia, Inc. | Heterocyclic cytokine inhibitors |
| CN103930165B (zh) * | 2011-09-02 | 2018-05-25 | 纽约市哥伦比亚大学理事会 | 用以治疗肥胖症的代谢紊乱的CaMKII、IP3R、钙调神经磷酸酶、P38和MK2/3抑制剂 |
| BR112020006677A2 (pt) | 2017-10-05 | 2020-10-06 | Fulcrum Therapeutics, Inc. | uso de inibidores p38 para reduzir a expressão de dux4 |
| US10342786B2 (en) | 2017-10-05 | 2019-07-09 | Fulcrum Therapeutics, Inc. | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4107288A (en) * | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US4619652A (en) * | 1982-12-23 | 1986-10-28 | Alza Corporation | Dosage form for use in a body mounted pump |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| US6096748A (en) * | 1996-03-13 | 2000-08-01 | Smithkline Beecham Corporation | Pyrimidine compounds useful in treating cytokine mediated diseases |
| GB9713726D0 (en) * | 1997-06-30 | 1997-09-03 | Ciba Geigy Ag | Organic compounds |
| BR9812944A (pt) * | 1997-10-20 | 2000-08-08 | Hoffmann La Roche | Inibidores bicìclicos da cinase |
| US6589954B1 (en) * | 1998-05-22 | 2003-07-08 | Scios, Inc. | Compounds and methods to treat cardiac failure and other disorders |
| US6599710B1 (en) * | 1999-03-10 | 2003-07-29 | The General Hospital Corporation | Treatment of autoimmune disease |
| JP2003500403A (ja) * | 1999-05-21 | 2003-01-07 | サイオス，インコーポレーテッド | ｐ３８キナーゼのインヒビターとしてのインドール型誘導体 |
-
2003
- 2003-12-05 JP JP2004558236A patent/JP2006510654A/ja active Pending
- 2003-12-05 AU AU2003299652A patent/AU2003299652A1/en not_active Abandoned
- 2003-12-05 WO PCT/US2003/040140 patent/WO2004053107A2/en not_active Ceased
- 2003-12-05 CA CA002511763A patent/CA2511763A1/en not_active Abandoned
- 2003-12-05 EP EP03799936A patent/EP1583535A4/en not_active Withdrawn
- 2003-12-05 US US10/728,665 patent/US20040171659A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11311535B2 (en) | Pancreatitis treatment | |
| NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| ITMI20031617A1 (it) | Microcapsule a doppio strato di polisaccaridi utilizzabili | |
| DK1572230T3 (da) | Placenta alkalisk phosphatase til at kontrollere diabetes | |
| JP2003520232A5 (https=) | ||
| JP2005237328A5 (https=) | ||
| DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
| JP2010502564A (ja) | 眼科用経皮吸収型製剤 | |
| CA2518219A1 (en) | Igf-binding protein-derived peptide or small molecule | |
| WO2005018605A3 (en) | Novel formulation of ropinirole | |
| WO2006070325A3 (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
| JP2005526024A5 (https=) | ||
| KR101432246B1 (ko) | 메포민을 포함하는 자가면역질환 예방 및 치료용 조성물 | |
| RU2006118786A (ru) | Твердый препарат | |
| JP2006510654A5 (https=) | ||
| CA2389032A1 (en) | Preventive or therapeutic agents for inflammatory diseases of intestine | |
| JP2008538362A (ja) | タンパク質の成熟の遮断を介して疾患を処置するための方法、タンパク質ジスルフィドイソメラーゼなどの分子シャペロンの機能を阻害する、またはグリコシル化を妨害する化合物、それらを含む薬学的組成物、および治療剤を同定するためのスクリーニング方法 | |
| WO2007092086A3 (en) | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels | |
| JP2007504268A5 (https=) | ||
| SE0002729D0 (sv) | Novel compound form | |
| EP1393738A4 (en) | MEDICINE AGAINST DIABETES | |
| RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
| NO20060651L (no) | Fremgangsmate for behandling av virale infeksjoner | |
| CA2504873A1 (en) | Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one | |
| KR20170124322A (ko) | 알러지 질환 치료제 전달을 위한 용해성 미세바늘 패치 |